InvestorsHub Logo

Mortimerduke

03/21/23 9:19 PM

#579230 RE: ATLnsider #579224

Agree. Those exposing their nitpicking surprised me.

hoffmann6383

03/21/23 9:38 PM

#579237 RE: ATLnsider #579224

well said atl!
Bullish
Bullish

CrashOverride

03/21/23 11:29 PM

#579254 RE: ATLnsider #579224

As always well said for good measure!

Know-Fear

03/22/23 2:32 AM

#579266 RE: ATLnsider #579224

Knowing there’s a pool started on revenue estimates for 2023 it will be interesting to see how #3 MIA impacts the revenue stream going forward. Not sure the early entrants in the pool are making a MIA splash or ripple with their respective estimates(calculus).

iclight

03/22/23 8:35 AM

#579302 RE: ATLnsider #579224

Getting discouraged and impatient is from the SP of this crappy investment, not outside voices.

SP is supposed to go up after milestones.

1-2) SP down %40
3) commercial manufacturing of ANY biologic Advent wishes to produce is approved. Most like there will never be more vaccines than the 3-4 specials a year.
4) patents for worthless unapproved products are worthless too.
5) Cognate was built for that and $100 million pumped into Cognate by NWBO shareholders with no benefit to NWBO shareholders
6) the SP threshold won't be met without an R/S. If TLD did not get it there, nothing will
7) Neither will happen. If the 2+ years since data lock have gone and they are not ready to submit, they have no plan to do so. What were the doing for 2+ years waitng for Advents approval to produce non-DCVax biologics?